Skip to main content
. 2022 Jul 15;97(5):612–623. doi: 10.1016/j.abd.2021.10.007

Table 1.

Characteristics of included studies: psoriasis and comorbidities.

Study Region Study period Data sources Mean age, (y); Female (%)
N° of psoriatic patients
N° of Control
Specific comorbidities NOS
Psoriasis Control All Comorbidities All Comorbidities
Ahlehoff O, 201130 Danish 2002–2006 The Danish National Patient Register 69.5 (12.1); 36.58 70.6 (13.5); 38.72 462 199 48935 20356 CVD, KD, PD 6
Ahlehoff O, 201231 Danish 1997.01–2006.12 The Danish National Patient Register 46.1 ± 16.9; 49.72 43.7 ± 19.7; 49.03 39558 530 4478926 55660 CVD, KD, CD, PD 7
Armstrong AW, 201332 US 2004–2009 University of California Davis 53 (40‒63); 59.19 53 (40‒63); 51.11 2078 1776 6234 3616 CVD, CD, PD 6
Charlton R, 201833 UK 1998.01–2014.12 The UK Clinical Practice Research Datalink 49 (39‒59); 50.95 49 (39‒59); 50.95 27132 8444 27132 7051 CVD, CD 7
Chiang CH, 201134 Taiwan Before 2007 Longitudinal Health Insurance Database 2007 45.3 ± 17.4; 43.69 43.5 ± 17.4; 22.14 2783 1066 13910 5145 CVD, KD 6
Feldman SR, 201535 US 2007.01–2012.03 The OptumHealth Reporting and Insights claims database 47.62; 44.50 47.62; 44.50 5492 881 5492 499 KD, CD, PD, LD 7
Khalid U, 201536 Danish 1997.01–2011.12 The Danish National Patient Register 43.3 (15.8); 51.48 41.9 (19.9); 5 0.71 70665 1292 5036959 105321 CVD, KD, PD 7
aLee S, 201737 US 2010.11–2015.10 The US Department of Defense population 48.1; 51.84 48.1; 51.84 7249 2932 72490 22367 CVD, CD 7
Min C, 201926 Korean 2002‒2013 The Korean National Health Insurance Service-National Sample Cohort NR; 43.32 NR; 43.32 11071 5187 44284 20298 CVD, CD 7
Prasada S, 202029 US 2000.01–2019.01 The Northwestern Medicine Enterprise Data Warehouse 49.72 (15.95); 51.71 48.60 (16.65); 57.34 5365 1536 19358 5241 CVD, KD 7
Schell C, 201538 German NR Eberhard Karls University Tübingen 48.3 ± 15.6; 43.33 49.1 ± 18.6; 60.00 300 158 300 150 CVD, KD, PD, LD 6
Tollefson MM, 201828 US 2004.01–2013.12 Optum Laboratories Data Warehouse 12.0 (4.4); 53.52 12.0 (4.4); 53.52 29957 1200 29957 646 CVD, LD 8
Vena GA, 201039 Italy 2001‒2005 The Health Search/Thales Database 52.5 (16.5); 47.41 52.4 (16.4); 52.59 3516 399 17580 1425 CVD, PD 6
Yang YW, 201127 Taiwan 2006.01–2007.12 Longitudinal Health Insurance Database2000 NR, >18; 32.58 NR, >18; 67.42 1685 1471 5055 3651 CVD, KD, CD, PD, LD 8
Yeung H, 201340 UK NR The Health Improvement Network 46 (37‒55); 49.43 46 (36‒55); 52.91 9035 1945 90350 17502 CVD, KD, CD, PD, LD 6

NR, Not Reported; NOS, Newcastle–Ottawa Quality Assessment Scale; CVD, Cardiovascular Disease; CD, Cerebrovascular Disease; KD, Kidney Disease; PD, Pulmonary Disease; LD, Liver Disease; US, United States; UK, United Kingdom.

a

The data of study included Psoriatic arthritis.37